Balachandra K. Gorentla, Ph.D. - Publications
Affiliations: | 2008 | The University of North Dakota, Grand Forks, ND, United States |
Area:
Molecular Biology, Neuroscience BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Moritz AE, Foster JD, Gorentla BK, Mazei-Robison MS, Yang JW, Sitte HH, Blakely RD, Vaughan RA. Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding. The Journal of Biological Chemistry. 288: 20-32. PMID 23161550 DOI: 10.1074/Jbc.M112.407874 | 0.631 | |||
2011 | Shen S, Wu J, Srivatsan S, Gorentla BK, Shin J, Xu L, Zhong XP. Tight regulation of diacylglycerol-mediated signaling is critical for proper invariant NKT cell development. Journal of Immunology (Baltimore, Md. : 1950). 187: 2122-9. PMID 21775687 DOI: 10.4049/Jimmunol.1100495 | 0.341 | |||
2011 | Gorentla BK, Wan CK, Zhong XP. Negative regulation of mTOR activation by diacylglycerol kinases. Blood. 117: 4022-31. PMID 21310925 DOI: 10.1182/Blood-2010-08-300731 | 0.369 | |||
2009 | Gorentla BK, Moritz AE, Foster JD, Vaughan RA. Proline-directed phosphorylation of the dopamine transporter N-terminal domain. Biochemistry. 48: 1067-76. PMID 19146407 DOI: 10.1021/Bi801696N | 0.633 | |||
2006 | Foster JD, Cervinski MA, Gorentla BK, Vaughan RA. Regulation of the dopamine transporter by phosphorylation. Handbook of Experimental Pharmacology. 197-214. PMID 16722237 DOI: 10.1007/3-540-29784-7_10 | 0.685 | |||
2005 | Gorentla BK, Vaughan RA. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation. Neuropharmacology. 49: 759-68. PMID 16181646 DOI: 10.1016/J.Neuropharm.2005.08.011 | 0.747 | |||
Show low-probability matches. |